Where is Artios Pharma headquartered?

Artios Pharma is located in Cambridge, england.

Who invested in Artios Pharma?

Artios Pharma has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Artios Pharma?

Artios Pharma closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

artiospharma.com

Artios Pharma

Artios is an England-based biotechnology company that researches and develops DNA damage response therapies for the treatment of cancer.

Business Model:

Revenue: $3M

Employees: 51-200

Geographic Data

Address: Babraham Research Campus

City: Cambridge

State: england

Zip: CB223FH

Country: GB

Financial Info

Stage:

series c

Raised Last:

$153M

Raised Total:

$271M

Social

Facebook

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Artios is an England-based biotechnology company that researches and develops DNA damage response therapies for the treatment of cancer.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
8/2018	Series B		$0	Andera Partners iBank Life Sciences Partners AbbVie Biotech Ventures Arix Bioscience IP Group Merck Capital Ventures Novartis Venture Fund Pfizer Venture Investments SV Health Investors Andera Partners iBank Life Sciences Partners AbbVie Biotech Ventures Arix Bioscience IP Group Merck Capital Ventures Novartis Venture Fund Pfizer Venture Investments SV Health Investors
12/2020	Venture Round	2	$30M	Merck Darmstadt Darmstadt Merck
7/2021	Series C		$153M	TCG X. Invus Deep Track Capital Sofinnova Partners Tetragon Financial Group RTW Investments LP Soleus Capital Piper Heartland Healthcare Capital CaaS Capital Management Schroders Capital Arix Bioscience plc SV Health Investors Andera Partners Life Sciences Partners M Ventures IP Group plc Novartis Venture Funds
9/2016	Seed Round	1	-	SV Health Investors SV Health Investors
9/2016	Series A		$0	Imperial Innovations SV Health Investors M Ventures Arix Bioscience AbbVie Biotech Ventures Imperial Innovations SV Health Investors M Ventures Arix Bioscience AbbVie Biotech Ventures
7/2021	Series C		$0	Tetragon Financial Group Limited Andera Partners Arix Bioscience Avidity Partners CaaS Capital Management Deep Track Capital Invus IP Group Life Sciences Partners M Ventures Novartis Venture Fund Omega Funds Pfizer Venture Investments Piper Sandler RTW Investments LLC Schroders Capital Sofinnova Partners Soleus Capital SV Health Investors TCG Crossover Tetragon Financial Group Limited Andera Partners Arix Bioscience Avidity Partners CaaS Capital Management Deep Track Capital Invus IP Group Life Sciences Partners M Ventures Novartis Venture Fund Omega Funds Pfizer Venture Investments Piper Sandler RTW Investments LLC Schroders Capital Sofinnova Partners Soleus Capital SV Health Investors TCG Crossover
9/2016	Series A		$33.2M	SV Life Sciences Merck Ventures Imperial Innovations Group plc Arix Bioscience plc AbbVie Ventures
8/2018	Series B		$84.3M	Andera Partners Life Sciences Partners Novartis Venture Funds Arix Bioscience plc SV Health Investors M Ventures IP Group plc
7/2021	Series C	20	$152.7M	Andera Partners Arix Bioscience Avidity Partners CaaS Capital Management Deep Track Capital Invus IP Group Life Sciences Partners M Ventures Novartis Venture Fund Omega Funds Pfizer Venture Investments Piper Sandler RTW Investments LLC Schroders Capital Sofinnova Partners Soleus Capital SV Health Investors TCG Crossover Tetragon Financial Group Limited Andera Partners Arix Bioscience Avidity Partners CaaS Capital Management Deep Track Capital Invus IP Group Life Sciences Partners M Ventures Novartis Venture Fund Omega Funds Pfizer Venture Investments Piper Sandler RTW Investments LLC Schroders Capital Sofinnova Partners Soleus Capital SV Health Investors TCG Crossover Tetragon Financial Group Limited
8/2018	Series B	10	$83M	Andera Partners iBank Life Sciences Partners Andera Partners iBank Life Sciences Partners
9/2016	Series A	5	$32.6M	Imperial Innovations SV Health Investors Imperial Innovations SV Health Investors
9/2016	Seed Round	1	-

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details